Physician profile
Rusha Jayesh Patel
NPI 1710121975
$11,145.89
in general payments reported to CMS, 2019-2025
9 companies · $2,882 in 2025
The $2,882 reported for 2025 was more than what 93% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $17.24 · 2021: $4,268 · 2022: $3,268 · 2023: $227 · 2024: $325 · 2025: $2,882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,000 · Food and Beverage: $974 · Travel and Lodging: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,000.00 |
| Food and Beverage | $974.48 |
| Travel and Lodging | $459.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,265.26 | 2019-2022 | |
| Kls-Martin L.P. | $2,459.45 | 2025 | |
| Baxter Healthcare | $403.71 | 2022-2023 | |
| Axogen | $384.98 | 2024-2025 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Stryker Corporation | $252.69 | 2021-2023 | Sonopet Iq |
| Acera Surgical, INC. | $211.71 | 2024-2025 | Restrata Wound Matrix |
| Polynovo North America LLC | $135.99 | 2024-2025 | Novosorb Btm |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Biocon Biologics INC | $14.86 | 2024 | Ogivri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rusha Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.